臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 总笔数 :0
	造访人次 : 52898711 在线人数 : 676 教育部委托研究计画计画执行:国立台湾大学图书馆

搜寻范围

进阶搜寻

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"ying chun shen"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 11-20 / 38 (共4页)
<< < 1 2 3 4 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2021-03-09T05:18:39Z	Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell lines	Ying-Chun Shen; Hsu C.; Chen J.-Y.; Cheng A.-L.
臺大學術典藏	2021-03-09T05:18:38Z	Molecular targeted therapy for advanced hepatocellular carcinoma	Ying-Chun Shen; Hsu C.; Cheng A.L.
臺大學術典藏	2021-03-09T05:18:38Z	Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma	Ou D.-L.; Ying-Chun Shen; Liang J.-D.; Liou J.-Y.; Yu S.-L.; Fan H.-H.; Wang D.-S.; Lu Y.-S.; Hsu C.; Cheng A.-L.
臺大學術典藏	2021-03-09T05:18:38Z	Sorafenib for the treatment of hepatocellular carcinoma across geographic regions	Hsu C.; Ying-Chun Shen; Cheng A.L.
臺大學術典藏	2021-03-09T05:18:38Z	Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia	Lin C.-H.; Liau J.-Y.; Lu Y.-S.; Huang C.-S.; Lee W.-C.; Kuo K.-T.; Ying-Chun Shen; Kuo S.-H.; Lan C.; Liu J.M.; Kuo W.-H.; Chang K.-J.; Cheng A.-L.
臺大學術典藏	2021-03-09T05:18:37Z	Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma	Hsu C.-H.; Ying-Chun Shen; Lin Z.-Z.; Chen P.-J.; Shao Y.-Y.; Ding Y.-H.; Hsu C.; Cheng A.-L.
臺大學術典藏	2021-03-09T05:18:37Z	Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B	Ko B.-S.; Chang T.-C.; Chen C.-H.; Liu C.-C.; Kuo C.-C.; Hsu C.; Ying-Chun Shen; Shen T.-L.; Golubovskaya V.M.; Chang C.-C.; Shyue S.-K.; Liou J.-Y.
臺大學術典藏	2021-03-09T05:18:37Z	Geographic difference in survival outcome for advanced hepatocellular carcinoma: Implications on future clinical trial design	Hsu C.; Ying-Chun Shen; Cheng C.-C.; Hu F.-C.; Cheng A.-L.
臺大學術典藏	2021-03-09T05:18:36Z	Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma	Shao Y.-Y.; Lin Z.-Z.; Hsu C.; Ying-Chun Shen; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2021-03-09T05:18:36Z	Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach	Ying-Chun Shen; Hsu C.; Chen L.-T.; Cheng C.-C.; Hu F.-C.; Cheng A.-L.

显示项目 11-20 / 38 (共4页)
<< < 1 2 3 4 > >>
每页显示[10|25|50]项目